Publication | Open Access
Clinical implications of germline BCL2L11 deletion polymorphism in pretreated advanced NSCLC patients with osimertinib therapy
20
Citations
14
References
2020
Year
Clinical ImplicationsGenetic DisorderGenetic EpidemiologyHuman PolymorphismPathologyPharmacogenomicsPharmacotherapyMedical GeneticsMolecular MedicineMedicineOsimertinib TherapyClinical Genetics
| Year | Citations | |
|---|---|---|
Page 1
Page 1